Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001779508 | SCV002015038 | likely benign | not specified | 2021-10-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002074068 | SCV002467412 | likely benign | Noonan syndrome 9 | 2023-12-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002074068 | SCV002763122 | likely benign | Noonan syndrome 9 | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV004040794 | SCV004957709 | likely benign | Cardiovascular phenotype | 2023-10-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |